TL;DR
Medicare has launched ACCESS, a decade-long pilot program that shifts reimbursement to reward health outcomes, including AI-driven care. While promising, widespread awareness and understanding in the tech industry are limited, raising questions about future adoption.
Medicare’s new program, ACCESS, officially launches on July 5, 2024, introducing a payment model that rewards health outcomes rather than traditional service volume, specifically accommodating AI-driven healthcare solutions. This shift marks a significant change in federal healthcare reimbursement policies, with implications for the tech industry’s involvement in health services.
ACCESS—short for Advancing Chronic Care with Effective, Scalable Solutions—is a 10-year initiative by the Centers for Medicare & Medicaid Services (CMS) that tests a new reimbursement framework. Unlike traditional Medicare, which pays based on clinician time, ACCESS provides predictable payments for managing chronic conditions, with full rewards only when patients meet specific health goals such as blood pressure control or reduced pain. This creates a funding pathway for AI tools that monitor patients continuously, coordinate care, or perform check-ins, which previously lacked reimbursement mechanisms.
One of the first participants, Pair Team, has been developing AI-enabled healthcare since 2019, focusing on vulnerable populations managing chronic illnesses alongside social challenges like housing instability. The company employs around 850 clinical professionals and has generated over nine figures in revenue. Its deployment of Flora, a voice AI agent, exemplifies the new model, as Flora handles patient intake, engagement, and referrals 24/7, significantly reducing avoidable hospital and ER visits.
Why It Matters
This development is significant because it signals a fundamental shift in healthcare reimbursement, opening the door for AI-driven solutions to be funded directly through federal programs. For the tech industry, this could accelerate innovation in digital health, remote monitoring, and AI-enabled patient engagement tools. However, the limited awareness among tech firms raises concerns about missed opportunities and the need for better communication about policy changes that could reshape healthcare technology investments.
AI Companion robot for Seniors and Dementia patients – using ChatGPT, Vision AI, and intelligent features to talk with seniors, support routines, and check for cognitive decline and dementia symptoms
- Emergency and Medication Alerts: Emergency calls, alarms, and guardian app
- Health Device Integration: Connects with blood pressure and glucose monitors
- Object & Face Recognition: Screens surroundings and analyzes users
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
Historically, Medicare reimbursed providers based on time spent with patients, creating little incentive for AI or remote monitoring tools. The CMS Innovation Center has experimented with various models over the past decade, but with mixed financial results. The design of ACCESS, crafted by former startup founders within CMS, emphasizes outcome-based payments and competitive enrollment, aiming to foster innovation while managing costs. The program’s focus on vulnerable populations—those with chronic conditions and social needs—reflects a broader policy shift toward social determinants of health.
“The government is creating swim lanes for AI innovation in traditionally regulated industries. The best solution wins, which, in healthcare, has not always been the case.”
— Neil Batlivala, CEO of Pair Team
“ACCESS is designed to test how outcome-based payments can accelerate innovation and improve care for high-need populations.”
— Abe Sutton, CMS Innovation Center Director
Telehealth and Remote Patient Monitoring Systems
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how widely the tech industry is aware of or prepared for this shift, as most of the sector has not been engaged in the program’s development. Additionally, concerns about data security, privacy, and the actual scalability of AI solutions under this model are still unresolved. The long-term financial and clinical impacts of the program are also yet to be determined, given the mixed results of past CMS innovation efforts.
The AI-Powered Fitness Coach: Custom Programs, Nutrition Plans & Client Engagement with AI (AI Workflow Series Book 16)
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Starting July 5, 2024, participating organizations will begin implementing AI-driven care models under ACCESS, with ongoing evaluation of health outcomes and cost savings. CMS will monitor the program’s effectiveness, and further policy adjustments may follow based on initial results. Increased industry awareness and engagement are expected as the program progresses.
Living a Healthy Life with Chronic Conditions: Self-Management of Heart Disease, Arthritis, Diabetes, Depression, Asthma, Bronchitis, Emphysema and Other Physical and Mental Health Conditions
- Product quality: Great product!
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the main purpose of the ACCESS program?
ACCESS aims to test a new payment model that rewards health outcomes for managing chronic conditions, including support for AI-driven healthcare solutions, over a 10-year period.
How does the new payment model differ from traditional Medicare?
Unlike traditional Medicare, which reimburses based on services provided, ACCESS offers predictable payments tied to patient health outcomes, incentivizing effective management and use of AI tools.
Why is most of the tech industry unaware of this development?
The program was designed within CMS by officials with startup backgrounds, and its rollout has not involved widespread industry outreach, leading to limited awareness among tech firms.
What are the risks associated with this new model?
Risks include data security concerns, especially given sensitive patient information involved, and financial risks if AI solutions do not meet expected health outcomes or if reimbursement rates are insufficient to sustain innovation.
What happens next in the implementation of ACCESS?
Organizations will begin deploying AI and other digital health tools starting July 5, with CMS closely monitoring results to inform future policy adjustments and broader adoption.
